REQUEST A DEMO
Total
USD $0.00
Search more companies

Lyra Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lyra Laboratories Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lyra Laboratories Private Limited is an unlisted company, incorporated on 25/04/2005. It has its registered office in the State of Himachal Pradesh, India. Company's corporate identification number (CIN) is U24230HP2005PTC028301 and registration number is 028301. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Baddi, Barotiwala Road,
Solan; Himachal Pradesh; Postal Code: 174103

Contact Details: Purchase the Lyra Laboratories Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Lyra Laboratories Private Limited report to view the information.
Outstanding Shares:
Purchase the Lyra Laboratories Private Limited report to view the information.
Registered Capital:
Purchase the Lyra Laboratories Private Limited report to view the information.
Incorporation Date:
April 25, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Lyra Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
18.74%
Total operating revenue
18.66%
Operating profit (EBIT)
49.99%
EBITDA
31.13%
Net Profit (Loss) for the Period
49.06%
Total assets
11.97%
Total equity
6.84%
Operating Profit Margin (ROS)
0.92%
Net Profit Margin
0.66%
Return on Equity (ROE)
1.81%
Debt to Equity Ratio
-0.37%
Quick Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?